Mimedx

MiMedx is a biopharmaceutical company specializing in regenerative medicine, primarily focused on developing and marketing human placental tissue allografts for various healthcare applications. They generate revenue through the sale of their proprietary products, which are used in wound care, surgical, sports medicine, and other medical fields to promote healing and reduce inflammation. Founded in 2008, MiMedx has undergone significant growth and transformation, including overcoming legal and financial challenges, to establish itself as a leader in the regenerative medicine industry.

Recent Posts by Mimedx

1-20 of 21